Schizophrenia
Research
The Florey has two laboratories conducting schizophrenia research:
- Neural Plasticity Laboratory led by A/Prof Anthony Hannan
- Brain Development Laboratory led by Prof Seong-Seng Tan
The Florey is also a research partner with the Melbourne Neuropsychiatry Centre.
Media Releases
Media Releases about the Florey’s schizophrenia research are available in the Media Centre.
Links
- Society for Neuroscience - advancing the understanding of the brain and nervous system
- Better Health Channel - health and medical information quality assured by the Victorian Government
- HealthInsite - an Australian Government Initiative
Australian Statistics
- Schizophrenia affects 1 in 100 Australians.
- In 2002, 40,000 Australians were diagnosed with schizophrenia.
- 60% of Australian males with schizophrenia will attempt suicide at some point in their lives.
- Approximately 1.5% of the Australian population will experience a schizophrenic episode during their lifetime.
The Brain
Neuropeptide Receptor Laboratory
Led by Dr Ross AD Bathgate, the Neuropeptide Receptor Laboratory studies the peptide hormones, relaxin, relaxin-3 and insulin-like peptide 3 (INSL3), and their numerous essential biological roles.